Resultados da busca - Ghady Haidar

Refinar Resultados
  1. 1
    Invasive Fungal Infections after Anti-CD19 Chimeric Antigen Receptor-Modified T-Cell Therapy: State of the Evidence and Future Directions

    Invasive Fungal Infections after Anti-CD19 Chimeric Antigen Receptor-Modified T-Cell Therapy: State of the Evidence and Future Directions por Will Garner, Palash Samanta, Ghady Haidar

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    Improving the Outcomes of Immunocompromised Patients With Coronavirus Disease 2019

    Improving the Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 por Ghady Haidar, John W. Mellors

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  3. 3
    Cytomegalovirus Infection in Solid Organ and Hematopoietic Cell Transplantation: State of the Evidence

    Cytomegalovirus Infection in Solid Organ and Hematopoietic Cell Transplantation: State of the Evidence por Ghady Haidar, Michael Boeckh, Nina Singh

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  4. 4
    COVID-19: Challenges of Viral Variants

    COVID-19: Challenges of Viral Variants por Jana L. Jacobs, Ghady Haidar, John W. Mellors

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  5. 5
    Immunocompromised Patients with Protracted COVID-19: a Review of “Long Persisters”

    Immunocompromised Patients with Protracted COVID-19: a Review of “Long Persisters” por M. Veronica Dioverti, Sonsoles Salto‐Alejandre, Ghady Haidar

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  6. 6
    Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients

    Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients por Mounzer Agha, Maggie Blake, Charles Chilleo, Alan Wells, Ghady Haidar

    Publicado em 2021
    Obter o texto integral
    Pré-impressão
    Salvar na lista
    Na minha lista:
  7. 7
    Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era

    Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era por Mounzer Agha, Maggie Blake, Charles Chilleo, Alan Wells, Ghady Haidar

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    Mutations in <i>bla</i> <sub>KPC-3</sub> That Confer Ceftazidime-Avibactam Resistance Encode Novel KPC-3 Variants That Function as Extended-Spectrum β-Lactamases

    Mutations in <i>bla</i> <sub>KPC-3</sub> That Confer Ceftazidime-Avibactam Resistance Encode Novel KPC-3 Variants That Function as Extended-Spectrum β-Lactamases por Ghady Haidar, Cornelius J. Clancy, Ryan K. Shields, Binghua Hao, Shaoji Cheng, M. Hong Nguyen

    Publicado em 2017
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  9. 9
    Identifying Spectra of Activity and Therapeutic Niches for Ceftazidime-Avibactam and Imipenem-Relebactam against Carbapenem-Resistant Enterobacteriaceae

    Identifying Spectra of Activity and Therapeutic Niches for Ceftazidime-Avibactam and Imipenem-Relebactam against Carbapenem-Resistant Enterobacteriaceae por Ghady Haidar, Cornelius J. Clancy, Liang Chen, Palash Samanta, Ryan K. Shields, Barry N. Kreiswirth, M. Hong Nguyen

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  10. 10
    Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape

    Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape por Kevin R. McCarthy, Linda J. Rennick, Sham Nambulli, Lindsey R. Robinson‐McCarthy, William Bain, Ghady Haidar, W. Paul Duprex

    Publicado em 2020
    Obter o texto integral
    Pré-impressão
    Salvar na lista
    Na minha lista:
  11. 11
    Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape

    Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape por Kevin R. McCarthy, Linda J. Rennick, Sham Nambulli, Lindsey R. Robinson‐McCarthy, William Bain, Ghady Haidar, W. Paul Duprex

    Publicado em 2021
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  12. 12
    Association between the Presence of Aminoglycoside-Modifying Enzymes and <i>In Vitro</i> Activity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae Carbapenemase- and Extended-Spectrum-β-Lactamase-Producing Enterobacter Species

    Association between the Presence of Aminoglycoside-Modifying Enzymes and <i>In Vitro</i> Activity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae... por Ghady Haidar, Ammar Alkroud, Shaoji Cheng, Travis M. Churilla, Bryce M. Churilla, Ryan K. Shields, Yohei Doi, Cornelius J. Clancy, M. Hong Nguyen

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  13. 13
    Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa

    Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa por Ryan K. Shields, Cornelius J. Clancy, A. William Pasculle, Ellen G. Press, Ghady Haidar, Binghua Hao, Liang Chen, Barry N. Kreiswirth, M. Hong Nguyen

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  14. 14
    Emergence of high-level aztreonam–avibactam and cefiderocol resistance following treatment of an NDM-producing <i>Escherichia coli</i> bloodstream isolate exhibiting reduced susceptibility to both agents at baseline

    Emergence of high-level aztreonam–avibactam and cefiderocol resistance following treatment of an NDM-producing <i>Escherichia coli</i> bloodstream isolate exhibiting reduced suscep... por Ghady Haidar, Ellen G Kline, Georgios D. Kitsios, Xiaohong Wang, E.J. Kwak, Anthony Newbrough, K J Friday, Kailey Hughes Kramer, Ryan K. Shields

    Publicado em 2024
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  15. 15
    Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.

    Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1. por Ryan K. Shields, Brian A. Potoski, Ghady Haidar, Binghua Hao, Yohei Doi, Liang Chen, Ellen G. Press, Barry N. Kreiswirth, Cornelius J. Clancy, M. Hong Nguyen

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  16. 16
    Rates of Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam Among Patients Treated for Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Bacteremia or Pneumonia

    Rates of Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam Among Patients Treated for Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Bacteremia or Pneumonia por Sunish Shah, Ellen G Kline, Ghady Haidar, Kevin M Squires, Jason M. Pogue, Erin K. McCreary, Justin Ludwig, Lloyd Clarke, Madison Stellfox, Daria Van Tyne, Ryan K. Shields

    Publicado em 2024
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  17. 17
    <i>In Vitro</i> Susceptibility of Multidrug-Resistant Pseudomonas aeruginosa following Treatment-Emergent Resistance to Ceftolozane-Tazobactam

    <i>In Vitro</i> Susceptibility of Multidrug-Resistant Pseudomonas aeruginosa following Treatment-Emergent Resistance to Ceftolozane-Tazobactam por Abigail M Rubio, Ellen G Kline, Chelsea E Jones, Liang Chen, Barry N. Kreiswirth, M. Hong Nguyen, Cornelius J. Clancy, Vaughn S. Cooper, Ghady Haidar, Daria Van Tyne, Ryan K. Shields

    Publicado em 2021
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  18. 18
    Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance

    Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance por Ghady Haidar, Nathan J Philips, Ryan K. Shields, Daniel J. Snyder, Shaoji Cheng, Brian A. Potoski, Yohei Doi, Binghua Hao, Ellen G. Press, Vaughn S. Cooper, Cornelius J. Clancy, M. Hong Nguyen

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  19. 19
    Metagenomic identification of severe pneumonia pathogens in mechanically-ventilated patients: a feasibility and clinical validity study

    Metagenomic identification of severe pneumonia pathogens in mechanically-ventilated patients: a feasibility and clinical validity study por Libing Yang, Ghady Haidar, Haris Zia, Rachel Nettles, Shulin Qin, Xiaohong Wang, Faraaz Shah, Sarah F. Rapport, Themoula Charalampous, Barbara A. Methé, Adam Fitch, Alison Morris, Bryan J. McVerry, Justin O’Grady, Georgios D. Kitsios

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  20. 20
    Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

    Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection por J Ryan Bariola, Erin K McCreary, Richard J. Wadas, Kevin E. Kip, Oscar C. Marroquin, Tami Minnier, Stephen Koscumb, Kevin Collins, Mark Schmidhofer, Judith A. Shovel, Mary Kay Wisniewski, Colleen Sullivan, Donald M. Yealy, David A. Nace, David T. Huang, Ghady Haidar, Tina Khadem, Kelsey Linstrum, Christopher Seymour, Stephanie K. Montgomery, Derek C. Angus, Graham M. Snyder

    Publicado em 2021
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: